[{"notes_id":"1_220","category":"5","subcategory":"2","title":"Chronic myeloid leukaemia","body":"The <span class=\"concept\" data-cid=\"9823\">Philadelphia chromosome<\/span> is present in more than 95% of patients with chronic myeloid leukaemia (CML). It is due to a <span class=\"concept\" data-cid=\"9823\">translocation between the long arm of chromosome 9 and 22 - t(9:22)(q34; q11)<\/span>. This results in part of the ABL proto-oncogene from chromosome 9 being fused with the BCR gene from chromosome 22. The resulting BCR-ABL gene codes for a fusion protein that has tyrosine kinase activity in excess of normal.<br \/><br \/>Presentation (60-70 years)<br \/><ul><li>anaemia: lethargy<\/li><li>weight loss and sweating are common<\/li><li><span class=\"concept\" data-cid=\"9315\">splenomegaly<\/span> may be marked &rarr; abdo discomfort<\/li><li><span class=\"concept\" data-cid=\"2354\">an increase in granulocytes at different stages of maturation +\/- thrombocytosis<\/span><\/li><li>decreased leukocyte alkaline phosphatase<\/li><li>may undergo blast transformation (AML in 80%, ALL in 20%)<\/li><\/ul><br \/>Management<br \/><ul><li>imatinib is now considered first-line treatment<ul><li><span class=\"concept\" data-cid=\"533\">inhibitor of the tyrosine kinase<\/span> associated with the BCR-ABL defect<\/li><li>very high response rate in chronic phase CML<\/li><\/ul><\/li><li>hydroxyurea<\/li><li>interferon-alpha<\/li><li>allogenic bone marrow transplant<\/li><\/ul>","notes_hash":"24b21248ff47f566e2b3005573f9765f","knowledge_graph_node_id_link":1079,"links":"","media":"<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/NTTIJR2RRYA\" data-description=\"Chronic leukemia\" data-upvotes=\"13\" data-downvotes=\"3\" data-media=\"386\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/NTTIJR2RRYA\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/NTTIJR2RRYA\" data-description=\"Chronic leukemia\" data-upvotes=\"13\" data-downvotes=\"3\" data-media=\"386\">Chronic leukemia<\/a><\/td><\/tr><tr><td><span ><small>Osmosis - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_664\" data-mediaid=\"664\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_664\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">13<\/span><button type=\"button\" style=\"\" id=\"media_dislike_664\" data-mediaid=\"664\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_664\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3<\/span><\/td><\/tr><tr><td>&nbsp;<\/td><\/tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/ST6mSB-RvE0\" data-description=\"Chronic myeloid leukaemia\" data-upvotes=\"1\" data-downvotes=\"2\" data-media=\"515\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/ST6mSB-RvE0\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/ST6mSB-RvE0\" data-description=\"Chronic myeloid leukaemia\" data-upvotes=\"1\" data-downvotes=\"2\" data-media=\"515\">Chronic myeloid leukaemia<\/a><\/td><\/tr><tr><td><span ><small>Khan Academy - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_895\" data-mediaid=\"895\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_895\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1<\/span><button type=\"button\" style=\"\" id=\"media_dislike_895\" data-mediaid=\"895\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_895\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2<\/span><\/td><\/tr><\/table>","concepts_for_notes":{"533":{"concept_text":"Chronic myeloid leukaemia - imatinib = tyrosine kinase inhibitor","concept_percentile":"48"}},"category_name":"Infectious disease \/ Haematology \/ Immunology","subcategory_name":"Haematology","comment_count":10},"",[]]